As such, in vivo and clinical data have excluded the possibility that antipsychotic medications lower S1P levels in schizophrenia, suggesting that abnormal S1P levels in schizophrenia are unlikely to be caused by antipsychotic mediations [33]. This evidence concerns the gene MBTPS1 and schizophrenia.